Online Business

India earmarks Rs 500 cr for IDPs in Lanka

India has earmarked Rs 500 crore for the relief and rehabilitation of the Internally Displaced Persons (IDPs) in Sri Lanka, Lok Sabha was informed today. - Krishna discusses Tamil resettlement with Lanka foreign minister - IMF inks pact with Sri Lanka on $2.5 bn loan - "PM"s observations on SL augurs well for renewed friendship" - WHO to conduct survey on health conditions in IDP camps - PM assures Lanka of all support for resettlement of IDPs - Ban did not discuss Kashmir with Pak PM: UN Minister of State for External Affairs Preneet Kaur, in a written reply, said the government is considering taking up several measures, including in the field of agriculture, in Sri Lanka with a view to facilitate rehabilitation of IDPs. "The government has earmarked Rs 500 crore for the relief and rehabilitation of the IDPs," she said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Add debt for portfolio stability
I am investing Rs 2,000 via SIPs in ICICI Infrastructure, Reliance Regular Savings Equity and Reliance Diversified Power Sector fund for the past 18 months. I want to continue investing in them for the next 10 years. Are these schemes good for the long term? I intend to invest another Rs 5,000 through SIPs. Please suggest whether I should increase the amount in the existing schemes or go for HDFC Top 200 and IDFC Premier Equity Plan A. I can take reasonable risk.
Popular Articles

CHESS #614
When reigning world champion Anatoly Karpov lost to Wolfgang Hartmann in Hanover in 1983, it created shock waves. The 27 year old Hartmann was a lowly 2290-rated player and no prodigy. By those standards, Anand’s last round defeat to Levon Aronyan at the Tal Memorial was mundane.

Aurobindo Pharma receives Swissmedic approval for cefepime for injection
Hyderabad-based Aurobindo Pharma Limited received approval from Swissmedic, an agency of Switzerland government for therapeutic products, for the licence of Cefepime APL for injection 1g and 2g.